Invivotek LLC is a fully integrated Contract Research Organization (CRO) based in Trenton, NJ, specializing in providing comprehensive drug discovery services to support clients' research programs from target discovery to clinical trials. They offer a wide range of pre-clinical services, including the evaluation of test therapeutics and phenotypic characterization of genetically modified rodent models of human disease. With expertise in areas such as Immunology and Inflammation, Diabetes, Cardiovascular, Obesity, Neurodegenerative disorders, and Cancer, Invivotek utilizes in vivo testing capabilities supported by biochemical and molecular biology techniques to study the mechanism of action of potential therapeutics and explore drug efficacy biomarkers.
As a proud member of Genesis Drug Discovery Development (GD3), Invivotek collaborates with this fully integrated CRO to provide comprehensive support throughout the drug discovery process, from target discovery to IND filing and managing Phase I-III clinical trials. Their portfolio includes both custom and standard pre-clinical services, offering bioassays designed to support in vivo testing of potential therapeutics. With a focus on traditional and genetically modified rodent models, Invivotek's services enable clients to gain valuable insights into the efficacy and mechanism of action of their test therapeutics, contributing to the advancement of drug discovery and development.
Generated from the website